<VariationArchive VariationID="1421943" VariationName="NM_000834.5(GRIN2B):c.3789_3837dup (p.Lys1280delinsGlyProAlaGlyCysProSerGlyGlyAspValLysArgLeuHisHisTer)" VariationType="Duplication" Accession="VCV001421943" Version="4" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-02-28" DateCreated="2022-03-28" MostRecentSubmission="2024-02-28">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1337557" VariationID="1421943">
      <GeneList>
        <Gene Symbol="GRIN2B" FullName="glutamate ionotropic receptor NMDA type subunit 2B" GeneID="2904" HGNC_ID="HGNC:4586" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>12p13.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="12" Accession="NC_000012.12" start="13537337" stop="13982134" display_start="13537337" display_stop="13982134" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="12" Accession="NC_000012.11" start="13714409" stop="14133021" display_start="13714409" display_stop="14133021" Strand="-" />
          </Location>
          <OMIM>138252</OMIM>
          <Haploinsufficiency last_evaluated="2019-09-25" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=GRIN2B">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2019-09-25" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=GRIN2B">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_000834.5(GRIN2B):c.3789_3837dup (p.Lys1280delinsGlyProAlaGlyCysProSerGlyGlyAspValLysArgLeuHisHisTer)</Name>
      <CanonicalSPDI>NC_000012.12:13563400:AGTGGTGGAGGCGTTTGACGTCACCGCCACTGGGGCAGCCGGCTGGTCCAGT:AGTGGTGGAGGCGTTTGACGTCACCGCCACTGGGGCAGCCGGCTGGTCCAGTGGTGGAGGCGTTTGACGTCACCGCCACTGGGGCAGCCGGCTGGTCCAGT</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>12p13.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="12" Accession="NC_000012.12" start="13563400" stop="13563401" display_start="13563400" display_stop="13563401" variantLength="49" positionVCF="13563400" referenceAlleleVCF="T" alternateAlleleVCF="TAGTGGTGGAGGCGTTTGACGTCACCGCCACTGGGGCAGCCGGCTGGTCC" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="12" Accession="NC_000012.11" start="13716334" stop="13716335" display_start="13716334" display_stop="13716335" variantLength="49" positionVCF="13716334" referenceAlleleVCF="T" alternateAlleleVCF="TAGTGGTGGAGGCGTTTGACGTCACCGCCACTGGGGCAGCCGGCTGGTCC" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000012.11" sequenceAccession="NC_000012" sequenceVersion="11" change="g.13716338_13716386dup" Assembly="GRCh37">
            <Expression>NC_000012.11:g.13716338_13716386dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000012.12" sequenceAccession="NC_000012" sequenceVersion="12" change="g.13563404_13563452dup" Assembly="GRCh38">
            <Expression>NC_000012.12:g.13563404_13563452dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_031854.2" sequenceAccession="NG_031854" sequenceVersion="2" change="g.423564_423612dup">
            <Expression>NG_031854.2:g.423564_423612dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000834.5" sequenceAccession="NM_000834" sequenceVersion="5" change="c.3789_3837dup" MANESelect="true">
            <Expression>NM_000834.5:c.3789_3837dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000825.2" sequenceAccession="NP_000825" sequenceVersion="2" change="p.Lys1280delinsGlyProAlaGlyCysProSerGlyGlyAspValLysArgLeuHisHisTer">
            <Expression>NP_000825.2:p.Lys1280delinsGlyProAlaGlyCysProSerGlyGlyAspValLysArgLeuHisHisTer</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001587" Type="nonsense" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="2136403635" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000834.5(GRIN2B):c.3789_3837dup (p.Lys1280delinsGlyProAlaGlyCysProSerGlyGlyAspValLysArgLeuHisHisTer) AND multiple conditions" Accession="RCV001923890" Version="3">
        <ClassifiedConditionList TraitSetID="21888">
          <ClassifiedCondition DB="MedGen" ID="C4015316">Developmental and epileptic encephalopathy, 27</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C3151411">Intellectual disability, autosomal dominant 6</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-08-31" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2022-08-31" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2022-03-28" MostRecentSubmission="2024-02-28">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <ConditionList>
          <TraitSet ID="21888" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="32574" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Epileptic encephalopathy, early infantile, 27</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Developmental and epileptic encephalopathy, 27</ElementValue>
                <XRef ID="MONDO:0014505" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">DEE27</ElementValue>
                <XRef Type="MIM" ID="616139" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="16063" />
                <XRef ID="16063" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">GRIN2B-related neurodevelopmental disorder is characterized by mild to profound developmental delay / intellectual disability (DD/ID) in all affected individuals. Muscle tone abnormalities (spasticity and/or hypotonia, occasionally associated with feeding difficulties), as well as epilepsy and autism spectrum disorder (ASD) / behavioral issues, are common. Other infantile- or childhood-onset findings include microcephaly; dystonic, dyskinetic, or choreiform movement disorder; and/or cortical visual impairment. Brain MRI reveals a malformation of cortical development in a minority of affected individuals. To date, fewer than 100 individuals with GRIN2B-related neurodevelopmental disorder have been reported.</Attribute>
                <XRef ID="NBK501979" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">29851452</ID>
                <ID Source="BookShelf">NBK501979</ID>
              </Citation>
              <XRef ID="3451" DB="Orphanet" />
              <XRef ID="C4015316" DB="MedGen" />
              <XRef ID="MONDO:0014505" DB="MONDO" />
              <XRef Type="MIM" ID="616139" DB="OMIM" />
            </Trait>
            <Trait ID="16103" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 6, WITH OR WITHOUT SEIZURES</ElementValue>
                <XRef Type="MIM" ID="613970" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Intellectual disability, autosomal dominant 6</ElementValue>
                <XRef ID="MONDO:0013509" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">MRD6</ElementValue>
                <XRef Type="MIM" ID="613970" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">GRIN2B-related neurodevelopmental disorder is characterized by mild to profound developmental delay / intellectual disability (DD/ID) in all affected individuals. Muscle tone abnormalities (spasticity and/or hypotonia, occasionally associated with feeding difficulties), as well as epilepsy and autism spectrum disorder (ASD) / behavioral issues, are common. Other infantile- or childhood-onset findings include microcephaly; dystonic, dyskinetic, or choreiform movement disorder; and/or cortical visual impairment. Brain MRI reveals a malformation of cortical development in a minority of affected individuals. To date, fewer than 100 individuals with GRIN2B-related neurodevelopmental disorder have been reported.</Attribute>
                <XRef ID="NBK501979" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="12851" />
                <XRef ID="12851" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">29851452</ID>
                <ID Source="BookShelf">NBK501979</ID>
              </Citation>
              <XRef ID="C3151411" DB="MedGen" />
              <XRef ID="MONDO:0013509" DB="MONDO" />
              <XRef Type="MIM" ID="613970" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="4214397" SubmissionDate="2024-02-15" DateLastUpdated="2024-02-28" DateCreated="2022-03-28">
        <ClinVarSubmissionID localKey="14535370|MedGen:CN224183;C3151411" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002192777" DateUpdated="2024-02-28" DateCreated="2022-03-28" Type="SCV" Version="3" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-08-31">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>This variant disrupts a region of the GRIN2B protein in which other variant(s) (p.Ala1315Val) have been determined to be pathogenic (Invitae). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site. ClinVar contains an entry for this variant (Variation ID: 1421943). This variant has not been reported in the literature in individuals affected with GRIN2B-related conditions. This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Lys1280Glyfs*17) in the GRIN2B gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 205 amino acid(s) of the GRIN2B protein. For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="GRIN2B" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000012.11:g.13716334_13716335insAGTGGTGGAGGCGTTTGACGTCACCGCCACTGGGGCAGCCGGCTGGTCC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease" multipleConditionExplanation="Uncertain">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN224183" Type="CUI" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C3151411" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11173117</SubmissionName>
          <SubmissionName>SUB12506961</SubmissionName>
          <SubmissionName>SUB14224806</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="4214397" TraitType="Disease" MappingType="XRef" MappingValue="C3151411" MappingRef="MedGen">
        <MedGen CUI="C3151411" Name="Intellectual disability, autosomal dominant 6" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4214397" TraitType="Disease" MappingType="XRef" MappingValue="CN224183" MappingRef="MedGen">
        <MedGen CUI="C4015316" Name="Developmental and epileptic encephalopathy, 27" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

